Abstract:To isolate and identify Akkermansia muciniphila AKK2645 from the feces of healthy Chinese children, systematically evaluate the safety of pasteurized AKK2645 as a probiotic strain for use in health food raw materials, and assess its ameliorative effects on high-fat diet (HFD)- induced metabolic syndrome in mice. The strain was identified using polyphasic taxonomy (morphology, physiology, biochemistry, and 16S rRNA gene sequencing). Genetic stability was assessed over 20 consecutive passages. Whole?genome sequencing was performed to analyze resistance, virulence, and pathogenicity?related genes. Pathogenicity was evaluated in mice via intraperitoneal injection and oral gavage. For the metabolic syndrome intervention experiment, male C57BL/6J mice were fed a high?fat diet for 8 weeks, concurrently gavaged daily with different doses of pasteurized AKK2645. Body weight, fasting blood glucose, glucose tolerance, serum lipids, and histopathological changes in liver and adipose tissues were measured. AKK2645 was identified as Akkermansia muciniphila. Colony morphology, biochemical reactions, and 16S rRNA gene sequences remained unchanged after 20 passages. No resistance, virulence, or pathogenicity genes were detected in the complete genome. No mortality, toxicity, or significant changes in body weight were observed in mice during the pathogenicity test. High?dose pasteurized AKK2645 (1×10? TFU/ml) reduced body weight by 9.61%, decreased the area under the glucose tolerance curve by 21.87%, and lowered serum triglycerides and total cholesterol by 62.78% and 41.35%, respectively. Hepatic steatosis, inguinal fat weight, and epididymal fat weight were reduced by 66.67% and 42.16%, respectively; brown adipocyte diameter decreased by 60.29%. Pasteurized AKK2645 meets the safety requirements for health food raw material strains in China and exerts significant ameliorative effects on metabolic syndrome in mice, demonstrating potential for translational application as a health food ingredient strain. ???